Abstract
No public abstract is available from the verified source records.
Open public full textRights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJulia Erin Wiedmeier-Nutor, Michael A. Golafshar, Katie L. Kunze, Edward D. Esplin, Robert L. Nussbaum, Erik Jessen, Brandie Heald, A. Keith Stewart, P. Leif Bergsagel, Rafael Fonseca
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
2023
Germline variants in targeted tumor sequencing using matched normal DNA
10.1001/jamaoncol.2015.5208 · 2016
Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol
10.1093/annonc/mdw018 · 2016
Germline analysis from tumor–germline sequencing dyads to identify clinically actionable secondary findings
10.1158/1078-0432.ccr-16-0015 · 2016
Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden
10.1002/ijc.24514 · 2009
Multiple myeloma and family history of lymphohaematopoietic cancers: results from the International Multiple Myeloma Consortium
10.1111/bjh.14199 · 2016
Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics
10.1182/blood-2011-11-387324 · 2012
Inherited genetic susceptibility to multiple myeloma
10.1038/leu.2013.344 · 2014
Characterization of rare germline variants in familial multiple myeloma
10.1038/s41408-021-00422-6 · 2021
Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1001/jamaoncol.2020.6252 · 2021
Identification of germline cancer predisposition variants during clinical ctDNA testing
10.1038/s41598-021-93084-0 · 2021
Yield and utility of germline testing following tumor sequencing in patients with cancer
10.1001/jamanetworkopen.2020.19452 · 2020
NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020
10.6004/jnccn.2020.0017 · 2020
NCCN guidelines® insights: genetic/familial high-risk assessment: colorectal, version 1.2021
2021
Confirmed pathogenic germline variants in cancer predisposition genes incidentally detected in somatic genomic profiling of multiple myeloma patients
10.1182/blood-2023-190878 · 2023
Pathogenic germline variants in multiple myeloma
10.1182/blood-2021-151495 · 2021
No additional external references are available.